Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Neurogen and Pfizer collaborate on development of NPY receptor ligands

Feb. 12, 1999

Genentech to withdraw support from pimagedine development

Feb. 11, 1999

Urologix's Targis System superior to alpha-blockers in BPH therapy

Feb. 11, 1999

Cathepsin L inhibitor isolated by Yamanouchi

Feb. 10, 1999

G120K-PEG: a specific renal GHR antagonist for the treatment of diabetic kidney disease

Feb. 10, 1999

Cholesterol-lowering action of troglitazone points to a potential new target for hypolipidemic drugs

Feb. 10, 1999

NIH to initiate clinical trials of Novavax's Novasome spermicide

Feb. 10, 1999

Metabolism of potent new progestagen examined in vitro and in vivo

Feb. 9, 1999

Positive results reported for Ergoset in insulin-treated type II diabetics

Feb. 9, 1999

Approval sought for intravenous Hectorol; FDA review status updated

Feb. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...